Emorhalt en es it fr

Emorhalt Brand names, Emorhalt Analogs

Emorhalt Brand Names Mixture

  • No information avaliable

Emorhalt Chemical_Formula


Emorhalt RX_link


Emorhalt fda sheet

Emorhalt FDA

Emorhalt msds (material safety sheet)

Emorhalt MSDS

Emorhalt Synthesis Reference

No information avaliable

Emorhalt Molecular Weight

388.458 g/mol

Emorhalt Melting Point

188.7 oC

Emorhalt H2O Solubility

40 mg/L

Emorhalt State


Emorhalt LogP


Emorhalt Dosage Forms

Capsules (300 mg) for oral administration; Suppositories (200 mg); Injectable (100 mg, 200 mg)

Emorhalt Indication

For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.

Emorhalt Pharmacology

Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ). In dogs pretreated with trimethobenzamide HCl, the emetic response to apomorphine is inhibited, while little or no protection is afforded against emesis induced by intragastric copper sulfate.

Emorhalt Absorption

The relative bioavailability of the capsule formulation compared to the solution is 100%.

Emorhalt side effects and Toxicity

Oral LD50 in mice is 1600 mg/kg.

Emorhalt Patient Information

No information avaliable

Emorhalt Organisms Affected

Humans and other mammals